Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Le Sourd

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinics and Research in Hepatology and Gastroenterology|March 12, 2026
Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancerEmeric Boisteau, Amandine Landrieux, Khemara Gnep, et al.
Cancers|May 16, 2023
<sup>188</sup>Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)Etienne Garin, Xavier Palard, Yan Rolland, et al.
Bulletin Du Cancer|November 8, 2016
[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma]Angélique Brunot, Amel M'Sadek, Florence Le Roy, et al.
British Journal of Cancer|October 9, 2023
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapyConstance d'Abrigeon, Mairéad G McNamara, Samuel Le Sourd, et al.
European Journal of Gastroenterology & Hepatology|July 20, 2021
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysisSoraya Benguerfi, Florian Estrade, Céline Lescure, et al.
Clinical Colorectal Cancer|April 24, 2017
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective StudyAnnie Lim, Samuel Le Sourd, Hélène Senellart, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Cancers|August 7, 2021
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular CarcinomaCéline Lescure, Florian Estrade, Maud Pedrono, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experienceHéloïse Bourien, Xavier Palard, Yan Rolland, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinomaXavier Palard, Julien Edeline, Yan Rolland, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinics and Research in Hepatology and Gastroenterology|March 12, 2026
Efficacy of haemostatic radiotherapy for bleeding related to nonoperable advanced gastric cancerEmeric Boisteau, Amandine Landrieux, Khemara Gnep, et al.
Cancers|May 16, 2023
<sup>188</sup>Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)Etienne Garin, Xavier Palard, Yan Rolland, et al.
Bulletin Du Cancer|November 8, 2016
[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma]Angélique Brunot, Amel M'Sadek, Florence Le Roy, et al.
British Journal of Cancer|October 9, 2023
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapyConstance d'Abrigeon, Mairéad G McNamara, Samuel Le Sourd, et al.
European Journal of Gastroenterology & Hepatology|July 20, 2021
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysisSoraya Benguerfi, Florian Estrade, Céline Lescure, et al.
Clinical Colorectal Cancer|April 24, 2017
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective StudyAnnie Lim, Samuel Le Sourd, Hélène Senellart, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Cancers|August 7, 2021
ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular CarcinomaCéline Lescure, Florian Estrade, Maud Pedrono, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experienceHéloïse Bourien, Xavier Palard, Yan Rolland, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2017
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinomaXavier Palard, Julien Edeline, Yan Rolland, et al.
Pageof 4